DIAPID

Pre-Launch

lypressin

Novartis
NDANASALSOLUTION
Lifecycle
Pre-Launch
Clinical Trials
1

Clinical Trials (1)

NCT01335516N/ACompleted

Follow-up of Glypressin (Terlipressin) Clinical Efficacy in the Treatment of Bleeding Oesophageal Varices

Started Nov 2010
20 enrolled
Gastrointestinal BleedingOesophageal Varices
Company
Novartis
Novartis
BASEL, Switzerland
646 open jobs
External Resources
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers